Figures
- FIGURE 1
Illustration of the different types of interstitial lung disease (ILD) associated with progressive pulmonary fibrosis. ILDs can be broadly categorised into connective tissue disease (CTD)-ILDs, other ILDs, and unclassifiable ILDs (uILDs). The CTD-ILDs are further sub-categorised based on the type of CTD, including rheumatoid arthritis-associated ILD, systemic sclerosis-associated ILD, mixed CTD-associated ILD, and other autoimmune ILDs. Other ILDs include exposure related ILDs (e.g. asbestosis and silicosis), non-idiopathic pulmonary fibrosis (such as genetic and/or familial pulmonary fibrosis (g/f PF)), idiopathic interstitial pneumonias (such as desquamative interstitial pneumonia), and others. HP: hypersensitivity pneumonitis; iNSIP: idiopathic nonspecific interstitial pneumonia; IPAF: interstitial pneumonia with autoimmune features; IPF: idiopathic pulmonary fibrosis.
- FIGURE 2
Summary of the current knowledge, gaps and opportunities for supportive care in needs identified by patients with pulmonary fibrosis. f-ILD: interstitial lung diseases associated with progressive pulmonary fibrosis; PR: pulmonary rehabilitation.
- FIGURE 3
Illustration of potential effects of supplemental oxygen in a patient with pulmonary fibrosis and hypoxaemia during exertion. Green lines represent potential responses with supplemental oxygen, and blue and red lines the potential responses without supplemental oxygen. Responses are not observed, the data for illustrational purposes only. Adapted from the presentation given by Magnus Ekström (Lund, Sweden) at the 2022 European Respiratory Society International Congress, with permission from the author.
